BioCentury
ARTICLE | Financial News

Delta-Fly raises ¥3.3B in IPO

October 5, 2018 7:53 PM UTC

Cancer company Delta-Fly Pharma Inc. (Tokyo:4598) raised ¥3.3 billion ($29.3 million) in IPO on Oct. 3 through the sale of 700,000 shares at ¥4,770.

The price values the company at ¥20.5 billion ($180.1 million). Delta-Fly had set a range of ¥4,570-¥4,770; at the ¥4,670 midpoint, it would have raised ¥3.3 billion ($28.7 million) for a valuation of ¥20.1 billion ($176.3 million)...

BCIQ Company Profiles

Delta-Fly Pharma Inc.